Insights
Thought Leadership
Patently Enabled April 2025 – Written Description in Life Sciences Patents: Avoiding Overreach
The purpose of this monthly series Patently Enabled is to share simplified patent-related information to assist non-patent practitioners in making the best decisions when considering their intellectual property rights.
In the April edition of Patently Enabled, Day Pitney Associate Erica Fishel and Partner Christopher Cowles examine the written description requirement in life sciences patents. They discuss key case law and practical strategies to ensure biotech and pharmaceutical patent claims are sufficiently supported and avoid overreach.
For any patent-related comments, questions or other inquiries, please contact patent attorneys Erica Fishel or Christopher Cowles.